94 related articles for article (PubMed ID: 26780985)
21. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731
[TBL] [Abstract][Full Text] [Related]
22. Identification of long-non coding RNA UCA1 as an oncogene in renal cell carcinoma.
Li Y; Wang T; Li Y; Chen D; Yu Z; Jin L; Ni L; Yang S; Mao X; Gui Y; Lai Y
Mol Med Rep; 2016 Apr; 13(4):3326-34. PubMed ID: 26935146
[TBL] [Abstract][Full Text] [Related]
23. FOXO-dependent expression of the proapoptotic protein Bim: pivotal role for apoptosis signaling in endothelial progenitor cells.
Urbich C; Knau A; Fichtlscherer S; Walter DH; Brühl T; Potente M; Hofmann WK; de Vos S; Zeiher AM; Dimmeler S
FASEB J; 2005 Jun; 19(8):974-6. PubMed ID: 15824087
[TBL] [Abstract][Full Text] [Related]
24. siRNA targeting survivin inhibits growth and induces apoptosis in human renal clear cell carcinoma 786-O cells.
Zhang Y; Chen ZD; Du CJ; Xu G; Luo W
Pathol Res Pract; 2009; 205(12):823-7. PubMed ID: 19628339
[TBL] [Abstract][Full Text] [Related]
25. Identification of miR‑130b as an oncogene in renal cell carcinoma.
Li Y; Chen D; Li Y; Jin L; Liu J; Su Z; Qi Z; Shi M; Jiang Z; Gui Y; Yang S; Mao X; Lai Y
Mol Med Rep; 2016 Feb; 13(2):1902-8. PubMed ID: 26717956
[TBL] [Abstract][Full Text] [Related]
26. The protein tyrosine phosphatase receptor type J is regulated by the pVHL-HIF axis in clear cell renal cell carcinoma.
Casagrande S; Ruf M; Rechsteiner M; Morra L; Brun-Schmid S; von Teichman A; Krek W; Schraml P; Moch H
J Pathol; 2013 Mar; 229(4):525-34. PubMed ID: 23007793
[TBL] [Abstract][Full Text] [Related]
27. The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma.
Sitaram RT; Cairney CJ; Grabowski P; Keith WN; Hallberg B; Ljungberg B; Roos G
Int J Cancer; 2009 Aug; 125(4):783-90. PubMed ID: 19384955
[TBL] [Abstract][Full Text] [Related]
28. pVHL/HIF-regulated CD70 expression is associated with infiltration of CD27+ lymphocytes and increased serum levels of soluble CD27 in clear cell renal cell carcinoma.
Ruf M; Mittmann C; Nowicka AM; Hartmann A; Hermanns T; Poyet C; van den Broek M; Sulser T; Moch H; Schraml P
Clin Cancer Res; 2015 Feb; 21(4):889-98. PubMed ID: 25691774
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-451a is associated with cell proliferation, migration and apoptosis in renal cell carcinoma.
Su Z; Ni L; Yu W; Yu Z; Chen D; Zhang E; Li Y; Wang Y; Li X; Yang S; Gui Y; Lai Y; Ye J
Mol Med Rep; 2015 Mar; 11(3):2248-54. PubMed ID: 25405789
[TBL] [Abstract][Full Text] [Related]
30. The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma.
Lichner Z; Scorilas A; White NM; Girgis AH; Rotstein L; Wiegand KC; Latif A; Chow C; Huntsman D; Yousef GM
Am J Pathol; 2013 Apr; 182(4):1163-70. PubMed ID: 23416164
[TBL] [Abstract][Full Text] [Related]
31. Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.
Lv D; Zhao W; Dong D; Qian XP; Zhang Y; Tian XJ; Zhang J
Eur J Cancer; 2011 Sep; 47(13):2068-76. PubMed ID: 21600761
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-21 stimulates epithelial-to-mesenchymal transition and tumorigenesis in clear cell renal cells.
Cao J; Liu J; Xu R; Zhu X; Liu L; Zhao X
Mol Med Rep; 2016 Jan; 13(1):75-82. PubMed ID: 26572589
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic inactivation of the candidate tumor suppressor gene ASC/TMS1 in human renal cell carcinoma and its role as a potential therapeutic target.
Liu Q; Jin J; Ying J; Cui Y; Sun M; Zhang L; Fan Y; Xu B; Zhang Q
Oncotarget; 2015 Sep; 6(26):22706-23. PubMed ID: 26093088
[TBL] [Abstract][Full Text] [Related]
34. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
[TBL] [Abstract][Full Text] [Related]
35. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.
Tang SW; Chang WH; Su YC; Chen YC; Lai YH; Wu PT; Hsu CI; Lin WC; Lai MK; Lin JY
Cancer Lett; 2009 Jan; 273(1):35-43. PubMed ID: 18809243
[TBL] [Abstract][Full Text] [Related]
36. HAVCR/KIM-1 activates the IL-6/STAT-3 pathway in clear cell renal cell carcinoma and determines tumor progression and patient outcome.
Cuadros T; Trilla E; Sarró E; Vilà MR; Vilardell J; de Torres I; Salcedo M; López-Hellin J; Sánchez A; Ramón y Cajal S; Itarte E; Morote J; Meseguer A
Cancer Res; 2014 Mar; 74(5):1416-28. PubMed ID: 24390735
[TBL] [Abstract][Full Text] [Related]
37. Human labour is associated with decreased cytoplasmic FoxO4.
Lim R; Riley C; Barker G; Rice GE; Lappas M
Placenta; 2012 Jan; 33(1):52-9. PubMed ID: 22112832
[TBL] [Abstract][Full Text] [Related]
38. Potential protective role of Grainyhead-like genes in the development of clear cell renal cell carcinoma.
Pawlak M; Kikulska A; Wrzesinski T; Rausch T; Kwias Z; Wilczynski B; Benes V; Wesoly J; Wilanowski T
Mol Carcinog; 2017 Nov; 56(11):2414-2423. PubMed ID: 28543713
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of miR-497 is associated with poor prognosis in renal cancer.
Zhao X; Zhao Z; Xu W; Hou J; Du X
Int J Clin Exp Pathol; 2015; 8(1):758-64. PubMed ID: 25755771
[TBL] [Abstract][Full Text] [Related]
40. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
